HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.22
−0.45%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+0.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Jolly Mohanjit · director | A-Award | 120,000 | $2.17 |
| Nov 19, 2025 | Pomichter Stanley D III · director | A-Award | 17,833 | $0.66 |
| Nov 18, 2025 | Jolly Mohanjit · director | A-Award | 454,456 | $0.00 |
| Nov 17, 2025 | Nelabhotla Venkateswarlu · director, officer: President and CEO | A-Award | 615,149 | $0.66 |
| Nov 17, 2025 | Tincoff John M. III · director | A-Award | 17,833 | $0.66 |
| Nov 17, 2025 | Sengupta Shiladitya · director | A-Award | 624,432 | $0.66 |
| Sep 22, 2025 | Nelabhotla Venkateswarlu · director, officer: President and CEO | A-Award | 7 | $0.00 |
| Sep 11, 2025 | Dickey Robert IV · officer: Chief Financial Officer | A-Award | 762 | $0.00 |
| Aug 13, 2024 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 48 | $0.25 |
| Aug 13, 2024 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 39 | $0.23 |
| Aug 13, 2024 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 43 | $0.17 |
| Aug 13, 2024 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 42 | $0.25 |
| Nov 8, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 131 | $0.27 |
| Nov 8, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 108 | $1.43 |
| Nov 8, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 39 | $1.42 |
| Nov 8, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 118 | $0.89 |
| Jul 19, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 106 | $1.47 |
| Jul 6, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 96 | $2.36 |
| Jul 6, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Purchase | 17,702 | $1.52 |
| Jul 6, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 109 | $2.60 |
| Jul 6, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 98 | $2.41 |
| Mar 7, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 157 | $13 |
| Mar 7, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 103 | $4.25 |
| Mar 7, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 48 | $7.49 |
| Mar 7, 2023 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 110 | $7.49 |
| Dec 20, 2022 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 2,213 | $0.15 |
| Dec 20, 2022 | STANKOVICH THOMAS · officer: Chief Financial Officer | A-Award | 364,756 | $0.00 |
| Dec 20, 2022 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 364,756 | $0.17 |
| Dec 20, 2022 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 5,144 | $0.15 |
| Nov 10, 2022 | STANKOVICH THOMAS · officer: Chief Financial Officer | Sale | 2,510 | $0.27 |
Institutional positioning
13F filings over the trailing two quarters
New 8Increased 5Reduced 1Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | New Position | 25,972 | Sep 2, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 25,793 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 25,793 | Aug 12, 2026 |
| UBS GROUP AG | Increased | 22,675 | May 5, 2026 |
| HRT FINANCIAL LP | New Position | 20,318 | Aug 14, 2026 |
| COLONY GROUP, LLC | Unchanged | 14,640 | May 15, 2026 |
| Focus Partners Wealth | Unchanged | 14,640 | Aug 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 12,195 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 12,195 | May 8, 2026 |
| UBS Group AG | Reduced | 11,908 | Aug 13, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 10,058 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 9,463 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 9,463 | May 15, 2026 |
| ROYAL BANK OF CANADA | Unchanged | 5,856 | May 15, 2026 |
| ROYAL BANK OF CANADA | Unchanged | 5,856 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026